Clinical efficacy of linezolid in the treatment of tuberculous meningitis: a retrospective analysis and literature review
Highlights Retrospective study evaluating linezolid in 99 TBM patients. Linezolid significantly reduced CSF protein levels, especially in critically ill patients. Similar adverse event rates between groups. Relevant literature reviews were reviewed.
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BMC
2025-04-01
|
| Rangatū: | BMC Infectious Diseases |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1186/s12879-025-10874-x |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|